Methotrexate

Treatment for Rheumatoid Arthritis

Typical Dosage: 7.5-25 mg once weekly

Effectiveness
75%
Safety Score
30%
Clinical Trials
693
Participants
150K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
30
DangerousModerateSafe
Treatment Details
Dosage Range
7.5-25 mg once weekly
Time to Effect
4-6 weeks
Treatment Duration
lifetime
Evidence Quality
HIGH
Number Needed to Treat (NNT)
3(Treat 3 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
10(Treat 10 patients to see 1 additional serious adverse event)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$100
Monitoring:$1,200
Side Effect Mgmt:$300
Total Annual:$1,600
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$15,000/QALY
QALYs Gained
1
Outcome-Based Costs
Cost per Responder
$2,461.54
Cost per Remission
$8,000
Methotrexate Outcomes

for Rheumatoid Arthritis

Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+65%
Remission Rate
+20%
Common Side Effects
Nausea
+30%
Fatigue
+20%
Hair thinning
+10%
Elevated liver enzymes
+15%
Mouth sores (stomatitis)
+10%
Myelosuppression
+5%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
7 active trials recruiting for Methotrexate in Rheumatoid Arthritis

Effect of MTX Discontinuation on Shingrix Response in RA

NCT06574594RECRUITINGNA
View Study
110 participants
INTERVENTIONAL
Seoul, South Korea
Started: Aug 22, 2024

MethMax Trial: MAXimising the METHotrexate Therapy Potential in Patients with Active Rheumatoid Arthritis

NCT06649136RECRUITINGPHASE4
View Study
182 participants
INTERVENTIONAL
Vienna, Austria
Started: Aug 12, 2024

Methotrexate in Patients with Early Rheumatoid Arthritis

NCT05353829ACTIVE NOT RECRUITINGPHASE4
View Study
212 participants
INTERVENTIONAL
Eskilstuna, Sweden +12 more
Started: Apr 28, 2022

Methotrexate Combined With Tofacitinib in Rheumatoid Arthritis

NCT06301373RECRUITINGNA
View Study
130 participants
INTERVENTIONAL
Guangzhou, China
Started: Sep 1, 2024

Natrunix in Combination With Methotrexate for Rheumatoid Arthritis Treatment

NCT06590090NOT YET RECRUITINGPHASE2
View Study
108 participants
INTERVENTIONAL
Started: Jul 15, 2026

Paroxetine Safety and Efficacy in Rheumatoid Arthritis

NCT06231745RECRUITINGPHASE3
View Study
100 participants
INTERVENTIONAL
Damietta, Egypt
Started: Jan 31, 2024

Cilostazol and Methotrexate in Rheumatoid Arthritis

NCT05594680RECRUITINGPHASE3
View Study
70 participants
INTERVENTIONAL
Al Mansurah, Egypt
Started: Oct 1, 2022
Completed Clinical Trials
9 completed trials for Methotrexate in Rheumatoid Arthritis

Study of the Efficacy and Safety of BCD-089 in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis

NCT04227366COMPLETEDPHASE3
View Study
154 participants
INTERVENTIONAL
Moscow, Russia
Started: Nov 19, 2019

PoC in Rheumatoid Arthritis With Methotrexate

NCT00605735COMPLETEDPHASE2
View Study
121 participants
INTERVENTIONAL
Palm Desert, United States +27 more
Started: Mar 1, 2008

Methotrexate Polyglutamate Levels as a Marker for the Clinical Outcome in the Treatment of Rheumatoid Arthritis

NCT00695188COMPLETEDPHASE4
View Study
19 participants
INTERVENTIONAL
Vienna, Austria +1 more
Started: May 1, 2008

Study of Two Different Starting Doses of Methotrexate When Starting Treatment in Rheumatoid Arthritis

NCT01404429COMPLETEDPHASE4
View Study
100 participants
INTERVENTIONAL
Chandigarh, India
Started: May 1, 2011

Comparison of Compliance and Evolution of Functional Capacity of Patients With Rheumatoid Arthritis Treated by Methotrexate Either by Auto-injector or by Conventional Sub-cutaneous Syringe

NCT02553018COMPLETEDPHASE3
View Study
278 participants
INTERVENTIONAL
Brest, France +1 more
Started: Sep 1, 2015

Efficacy and Safety of TAK-783 in Subjects With Rheumatoid Arthritis

NCT00760968COMPLETEDPHASE2
View Study
224 participants
INTERVENTIONAL
Brno-Bohunice, Czechia +24 more
Started: Aug 1, 2007

Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis

NCT00565409COMPLETEDPHASE4
View Study
834 participants
INTERVENTIONAL
Campsie, Australia +80 more
Started: Mar 1, 2008

ACP-196 Versus Placebo in Subjects With Rheumatoid Arthritis on Background Methotrexate

NCT02387762COMPLETEDPHASE2
View Study
31 participants
INTERVENTIONAL
Anniston, United States +16 more
Started: Apr 1, 2015

A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging Study

NCT00396747COMPLETEDPHASE4
View Study
45 participants
INTERVENTIONAL
Brussels, Belgium
Started: Jun 1, 2003
Showing 20 of 693 total trials